Benitec Biopharma (BNTC) Retained Earnings (2019 - 2025)
Benitec Biopharma (BNTC) posted Retained Earnings of -$883000.0 for Q4 2025, up 99.63% sequentially from -$237.1 million in Q3 2025, and down 28.34% YoY from -$1.2 million in Q4 2024.
Benitec Biopharma (BNTC) Retained Earnings (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Retained Earnings for 7 years, with the latest figure at -$883000.0 in Q4 2025.
- Quarterly Retained Earnings fell 28.34% year-over-year to -$883000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$883000.0 (down 28.34% YoY) and the FY2025 annual result came in at -$839000.0, up 99.56% from the prior year.
- Retained Earnings climbed to -$883000.0 in Q4 2025 per BNTC's latest filing, from -$237.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$688000.0 in Q4 2024 and troughed at -$237.1 million in Q3 2025.
- A 5-year average of -$96.8 million and a median of -$136.7 million in 2021 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings sank 23539.84% in 2023, then soared 99.62% in 2024.
- Over 5 years, Retained Earnings stood at -$1.3 million in 2021, then slumped by 12376.9% to -$158.8 million in 2022, then declined by 14.12% to -$181.3 million in 2023, then jumped by 99.62% to -$688000.0 in 2024, then retreated by 28.34% to -$883000.0 in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$883000.0, -$237.1 million, and -$839000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | -883,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -883,000.00 |
| Sep 30, 2025 | -237.14 Mn |
| Jun 30, 2025 | -839,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -688,000.00 |
| Sep 30, 2024 | -195.32 Mn |
| Jun 30, 2024 | -190.26 Mn |
| Mar 31, 2024 | -185.54 Mn |
| Dec 31, 2023 | -181.26 Mn |
| Sep 30, 2023 | -174.46 Mn |
| Jun 30, 2023 | -167.89 Mn |
| Mar 31, 2023 | -163.23 Mn |
| Dec 31, 2022 | -158.83 Mn |
| Sep 30, 2022 | -738,000.00 |
| Jun 30, 2022 | -1.25 Mn |
| Mar 31, 2022 | -143.26 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.22 Mn |
| Jun 30, 2021 | -130.12 Mn |
| Mar 31, 2021 | -1.59 Mn |